Galventa (private company)

See something wrong or missing? Let us know
Offices:St Gallen
Business model:B2B

Galventa is working for the development of the world-first nutraceutical product - B・SYNC ON - a supplement used to control the wake-up process

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 807k


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Galventa

Name Criteria
Norway Alginor
55%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden Pila Pharma
55%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Denmark Cytoki Pharma
55%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden Intrance Medical Systems
55%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden Aegirbio
50%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
Denmark Ferrosan Medical Devices
50%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
Denmark Octarine Bio
50%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
Finland Brinter
50%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
Spain Polimerbio
47%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Sweden PeptiSystems
47%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Top